ASO Visual Abstract: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

MLA

Tonello, M., et al. ASO Visual Abstract: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0e686898c7c38ed68e574fc6bfccbb9f&authtype=sso&custid=ns315887.

APA

Tonello, M., Baratti, D., Sammartino, P., Di Giorgio, A., Robella, M., Sassaroli, C., Framarini, M., Valle, M., Macri, A., Graziosi, L., Coccolini, F., Lippolis, P. V., Gelmini, R., Deraco, M., Biacchi, D., Santullo, F., Vaira, M., Di Lauro, K., D’Acapito, F., … Sommariva, A. (2022). ASO Visual Abstract: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Chicago

Tonello, M., D. Baratti, P. Sammartino, A. Di Giorgio, M. Robella, C. Sassaroli, M. Framarini, et al. 2022. “ASO Visual Abstract: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0e686898c7c38ed68e574fc6bfccbb9f&authtype=sso&custid=ns315887.